Masimo Corp
Masimo Corp logo
MASI

Masimo Corp (MASI)

$144.943.05%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$139.86
Day's Range
$145.06
$108.89
52-Week Range
$299.78
1 month return6.88%
3 month return5.94%
1 year return49.43%
5 year return58.32%

Company Information

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Masimo's mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.4 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,5 improve CCHD screening in newborns,6 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.7-10 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,11 and is the primary pulse oximetry at 9 of the top 10 hospitals according to the 2020-21 U.S. News and World Report Best Hospitals Honor Roll.12 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient's physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView :60™, and Masimo SafetyNet™.
OrganizationMasimo Corp
Employees2200
CEOMr. Joseph E. Kiani
IndustryHealth Technology

Analyst Recommendation

based on 9 analysts ratings

Buy
66%
Buy
22%
Hold
11%
Sell

Based on 9 Wall street analysts offering stock ratings for Masimo Corp(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 7.4%

Current

$144.94

Target

$155.67

Recommendation Trend

Based on 9 analyst

Current1M Ago3M Ago
Buy
6
9
7
Hold
2
4
5
Sell
1
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
7.5B
Book Value
$23.83
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
2.97
PE Ratio
47.8
PEG Ratio
4.73
Wall Street Target Price
155.67

Valuation

Trailing PE47.8
Forward PE40.0
Price/Book (mrq)
6.0
Enterprise Value
8.3B
Enterprise Value/Revenue
4.77
Enterprise Value/Ebitda
28.3

Technicals

Beta
0.86
50 Day MA
136.22
200 Day MA
142.27

Institutional Holdings

Politan Capital Management LP

8.84%

Vanguard Group Inc

8.8%

FMR Inc

4.0%

State Street Corporation

3.15%

RTW INVESTMENTS, LLC

2.57%

Liontrust Investment Partners LLP

2.28%

Discover more

Frequently Asked Questions

What is Masimo Corp share price today?

Can Indians buy Masimo Corp shares?

How can I buy Masimo Corp shares from India?

Can Fractional shares of Masimo Corp be purchased?

What are the documents required to start investing in Masimo Corp stocks?

What are today’s High and Low prices of Masimo Corp?

What are today’s traded volumes of Masimo Corp?

What is today’s market capitalisation of Masimo Corp?

What is the 52 Week High and Low Range of Masimo Corp?

How much percentage Masimo Corp is down from its 52 Week High?

How much percentage Masimo Corp is up from its 52 Week low?

What are the historical returns of Masimo Corp?

Who is the Chief Executive Officer (CEO) of Masimo Corp?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*